To obtain a more comprehensive analysis of the changes induced by IL-32 within the TME and systemically, we analyzed primary B16F10 tumor homogenates and sera from IL-32– and PBS-treated mice for the expression of 44 key cytokines and chemokines using an addressable laser bead immunoassay (ALBIA). This evidence concerns the gene IL32 and neoplasm.